Skip to main content

MoneyWorks4Me

NATCO Pharma submits investor presentation

19 Aug 2026 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, NATCO Pharma has informed that it enclosed the Investor Presentation.

The above information is a part of company’s filings submitted to BSE.  

Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..